Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment.
DʼAvolio A, Ciancio A, Siccardi M, Smedile A, Baietto L, Simiele M, Marucco DA, Cariti G, Calcagno A, de Requena DG, Sciandra M, Cusato J, Troshina G, Bonora S, Rizzetto M, Di Perri G.
DʼAvolio A, et al. Among authors: cusato j.
Ther Drug Monit. 2012 Apr;34(2):165-70. doi: 10.1097/FTD.0b013e31824bf778.
Ther Drug Monit. 2012.
PMID: 22406654
Free article.